Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts
NCT07534865 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210
Last updated 2026-04-16
Summary
Hyperthermia treatment (hyperthermia) refers to treating diseases with temperature (39-45 ° C) beyond normal body temperature,. It has been reported that local warming at 44 ° C is able to effectively mobilize the body's immunity and clear HPV infected lesions, such as condyloma acuminatum and verruca vulgaris, etc. Significant progress has been made in the application of hyperthermia for viral skin diseases. Clinically, the addition of hydrogen peroxide solution can enhance the efficacy of hyperthermia in treating HPV infection. As a common transdermal drug delivery method, microneedles can increase drug penetration and thereby further improve treatment outcomes. Based on these findings, this study aims to explore an adjunctive approach to hyperthermia for treating viral warts to further enhance therapeutic efficacy.
This study employs a randomized, parallel-group, assessor-blinded design. Participants will be randomly assigned to three groups: hyperthermia alone, hyperthermia combined with microneedle patch (loaded with 0.9% saline), and hyperthermia combined with hydrogen peroxide microneedle patch (experimental group). An adaptive design will be adopted. The sample size is estimated at 70 participants per group, accounting for a potential 20% dropout rate. Interim analyses will be conducted during follow-up, and enrollment will be stopped when a positive result is reached for the primary efficacy endpoint (cure rate), at which point the sample size will be adjusted accordingly.
Conditions
- Warts
Interventions
- DRUG
-
3% hydrogen peroxide solution
Dressing: Like the Local Hyperthermia Group, use a microneedle patch loaded with 3% hydrogen peroxide . Irradiation: For seven sessions in three weeks, use simulated infrared light (without heat) with the same frequency as the Local Hyperthermia Group. Local Hyperthermia treats the target warts(largest and most severe warts), while medication addresses all warts.
- DRUG
-
0.9 % saline
Dressing: Like the Local Hyperthermia Group, use a microneedle patch loaded with 0.9% saline. Irradiation: For seven sessions in three weeks, use simulated infrared light (without heat) with the same frequency as the Local Hyperthermia Group. Local Hyperthermia treats the target warts(largest and most severe warts), while medication addresses all warts.
- DEVICE
-
Hyperthermia at 44℃
The infrared hyperthermia device was used as follows: based on the thermal tolerance of different body surface areas, the surface temperature was set to 44 °C ± 1 °C. The lesion was disinfected with alcohol. After the skin had dried, the patient's most painful or largest wart was selected as the target lesion and treated with 44 °C hyperthermia. The treatment was administered for three consecutive days (sessions), each lasting 30 minutes. After an interval of 7-10 days, the same target lesion received two consecutive days (sessions) of treatment, followed by one session every 7-10 days thereafter. For patients with multiple lesions, only one target lesion was treated using the above protocol, while the remaining lesions received no intervention.
- DEVICE
-
Microneedle patch
Purpose: To facilitate drug loading. Instructions:Add an appropriate amount of 3% hydrogen peroxide solution or 0.9% sodium chloride solution into the corresponding chamber. Apply the microneedle patch to the wart and secure it with tape. Press the raised part of the aluminum film sequentially with fingers until the chamber fully collapses and makes contact with the skin. After one hour of contact, dispose of the patch in a medical waste container.
Sponsors & Collaborators
-
First Hospital of China Medical University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-01
- Primary Completion
- 2028-12-01
- Completion
- 2028-12-01
Countries
- China
Study Locations
More Related Trials
-
Efficacy and Safety of Platelet-rich Plasma, Metformin and Cryotherapy in Treatment of Non-genital Warts
NCT06691542 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Topical Methotrexate Gel 1% Coupled With Microneedling in Treatment of Warts
NCT05300009 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Efficacy of Cryotherapy Combined With Intralesional Hepatitis B Virus Vaccine Versus Either Therapy in the Treatment of Multiple Cutaneous Warts :a Comparative Study
NCT05902624 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Comparative Study of Occlusive Heat Patch in the Treatment of Warts
NCT01746056 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts
NCT04288817 ·Status: UNKNOWN ·Phase: PHASE3
-
Carbon Dioxide Laser and Cryotherapy in Treatment of Warts
NCT03166137 ·Status: UNKNOWN ·Phase: NA
-
the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.
NCT07396714 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
New Treatment of Common Wart
NCT07543926 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy of Laser Versus Cryotherapy in the Treatment of Warts
NCT01808443 ·Status: COMPLETED ·Phase: NA
-
Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital Warts
NCT03948321 ·Status: UNKNOWN ·Phase: NA
-
Photodynamic Therapy in Treatment of Verrucae
NCT04620785 ·Status: UNKNOWN ·Phase: NA
-
Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts
NCT05617950 ·Status: UNKNOWN ·Phase: NA
-
Microneedling Alone Versus Microneedling Coupled With Either Bleomycin or 5flourouracil in the Treatment of Plantar Warts
NCT07041749 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients
NCT03153566 ·Status: UNKNOWN ·Phase: PHASE3
-
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
NCT03981822 ·Status: COMPLETED ·Phase: PHASE2
-
Intralesional Versus Intramuscular Hepatitis B Vaccine Immunotherapy for Warts
NCT05326152 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts
NCT05712811 ·Status: COMPLETED ·Phase: NA
-
A Study of A-101 Solution in Subjects With Common Warts.
NCT02669862 ·Status: COMPLETED ·Phase: PHASE2
-
Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts
NCT05023408 ·Status: COMPLETED ·Phase: PHASE2
-
Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.
NCT06261684 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts
NCT04814446 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
NCT01796795 ·Status: SUSPENDED ·Phase: PHASE2
-
The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts
NCT03477448 ·Status: UNKNOWN ·Phase: PHASE4
-
Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts
NCT03183765 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light - a Randomized Controlled Trial
NCT00254280 ·Status: UNKNOWN ·Phase: NA